Cushing's disease, medically referred to as hyperadrenocorticism, is a widespread endocrine disorder predominantly affecting middle-aged and elderly canines. This condition arises when a dog's body generates an excessive amount of cortisol, a hormone vital for metabolic regulation, stress response, and various physiological functions. While a complete cure is rarely achievable, early detection and appropriate management are crucial for controlling symptoms and vastly improving the affected dog's well-being.
This endocrine imbalance is primarily linked to two key glands: the pituitary gland and the adrenal glands. The pituitary gland, situated at the brain's base, produces adrenocorticotropic hormone (ACTH), which signals the adrenal glands (located above the kidneys) to produce cortisol. In healthy dogs, a regulatory feedback system ensures cortisol levels remain balanced. However, in dogs with Cushing's, this system falters, leading to persistent overproduction of cortisol. The resulting hormonal excess can manifest in a variety of symptoms, including heightened thirst, increased appetite, frequent urination, and excessive panting, alongside more severe health complications that can significantly diminish a dog's quality of life if not addressed.
Cushing's disease typically presents in two primary forms: pituitary-dependent hyperadrenocorticism and adrenal-dependent hyperadrenocorticism. Pituitary-dependent cases, which are more common, are caused by a benign tumor in the pituitary gland. This tumor continuously releases ACTH, leading to the enlargement of both adrenal glands and subsequent overproduction of cortisol. Advanced imaging techniques such as CT scans or MRIs are often necessary to pinpoint such pituitary tumors. In contrast, adrenal-dependent Cushing's disease stems from a tumor, which can be benign or malignant, on one of the adrenal glands. This tumor directly produces excessive cortisol, with only the affected adrenal gland typically showing enlargement. Diagnosis for this type usually involves abdominal ultrasound or CT imaging to assess the adrenal glands.
The diagnosis of Cushing's disease involves a comprehensive approach, beginning with a thorough physical examination and review of the dog's medical history and current medications. If the condition is suspected, specialized diagnostic tests are performed. The low-dose dexamethasone suppression test (LDDST) is a common initial screening, evaluating how well cortisol production is suppressed after the administration of dexamethasone. The ACTH stimulation test is another key diagnostic tool, measuring the adrenal glands' response to ACTH by comparing cortisol levels before and after stimulation. Further tests, including high-dose dexamethasone suppression tests, additional imaging, and routine blood work and urinalysis, help differentiate between pituitary-dependent and adrenal-dependent forms and assess overall health, often revealing elevated cholesterol, triglycerides, and changes in white blood cell counts.
Managing Cushing's disease is generally a lifelong commitment centered on controlling cortisol levels and alleviating symptoms to maintain a good quality of life. Although a cure is rare, successful management is often achieved through medication. Trilostane (Vetoryl®), a steroid analogue that inhibits cortisol production, is a commonly preferred treatment. Mitotane (Lysodren®), a chemotherapeutic agent that selectively destroys parts of the adrenal gland, is another option. Surgical intervention may be considered for adrenal-dependent cases, particularly if the tumor type and the dog's overall health are favorable. However, surgery and radiation therapy for pituitary-dependent cases are less common due to limited availability and potential complications. Dietary adjustments, specifically low-fat prescription diets, are also frequently recommended to manage elevated cholesterol and triglyceride levels often associated with the disease.
Ongoing monitoring is essential for dogs with Cushing's disease. This includes regular veterinary checkups, routine blood tests, and periodic ACTH stimulation tests to ensure the treatment remains effective and medication dosages are appropriate. Owners must closely observe their dogs for any changes in symptoms, such as increased thirst or urination, and report these to their veterinarian promptly, as dosage adjustments may be necessary. While naturally occurring Cushing's cannot be prevented, iatrogenic Cushing's (caused by long-term corticosteroid use) can often be avoided through careful medication management. Most affected dogs have a life expectancy of one to five years post-diagnosis, with the prognosis influenced by the disease type, early diagnosis, chosen treatment, and the dog's response to therapy. With diligent care and monitoring, many dogs can enjoy a good quality of life for several years.